Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05560100 · ClinicalTrials.gov registry record
Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling
A clinical trial, sponsored by Youngstown State University.
- Completed
- Registry status
- 5
- Enrollment target
NCT05560100: Completed study, sponsored by Youngstown State University.
NCT05560100 is a clinical trial that has completed, run by Youngstown State University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05560100 has completed, sponsored by Youngstown State University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to consider how such information should be presented during the informed consent process to improve an individual's ability to make a sound decision regarding their own personal care.
Primary Outcome
Contains questions about the characteristics of the participants
Interventions
- OTHER Nominal Group Technique - 2 to 3 hour virtual meeting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2022-10-31 |
What the finished NCT05560100 record still lists
NCT05560100 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Nominal Group Technique - 2 to 3 hour virtual meeting is the first listed.
NCT05560100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05560100 about?
NCT05560100 is a clinical study titled "Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling". As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to ...
What is the current status of trial NCT05560100?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2022-09-19. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05560100?
The interventions under investigation include: Nominal Group Technique - 2 to 3 hour virtual meeting (OTHER).
Who is sponsoring clinical trial NCT05560100?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI